Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022

Martyn Boutelle's Biography



Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College.
His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.

Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Martyn Boutelle Image

Towards Wearable Biosensing Technologies

Wednesday, 22 June 2022 at 11:00

Add to Calendar ▼2022-06-22 11:00:002022-06-22 12:00:00Europe/LondonTowards Wearable Biosensing TechnologiesPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

The concentration of biomarker molecules can give important information about the physiological ‘well-being’ of a person.  In Healthcare this is emerging as the personalization of healthcare – where data is used to track the progression of illness and the effects of treatment in a patient at the individual level, rather than using the population average. In lifestyle/fitness monitoring data can track the move from ‘wellness’ to exhaustion, fatigue, and dehydration. Our view is that to do such monitoring effectively ideally requires moment-by-moment measurement of concentration. One approach to this is using robust sensors controlled by to miniaturized wearable instrumentation.  We have been developing a range of biosensing solutions for the invasive, minimally invasive, and non-invasive monitoring of people. I will describe the key challenges in the development of such wearable biosensing devices and present recent data demonstrating personal chemical monitoring in the fitness and healthcare realms.


Add to Calendar ▼2022-06-21 00:00:002022-06-22 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2022Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com